Abivax S.A.
ABVX.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €421,040 | €426,941 | €806,616 | €493,241 |
| - Cash | €60,946 | €144,221 | €222,317 | €251,942 |
| + Debt | €98,708 | €96,195 | €113,362 | €55,464 |
| Enterprise Value | €458,802 | €378,915 | €697,661 | €296,763 |
| Revenue | €2,017 | €4,006 | €6,786 | €2,245 |
| % Growth | -49.7% | -41% | 202.3% | – |
| Gross Profit | €2,017 | €4,006 | €6,786 | €1,867 |
| % Margin | 100% | 100% | 100% | 83.2% |
| EBITDA | -€93,594 | -€91,847 | -€79,825 | -€90,047 |
| % Margin | -4,640.3% | -2,292.7% | -1,176.3% | -4,011% |
| Net Income | -€100,784 | -€94,604 | -€81,638 | -€95,787 |
| % Margin | -4,996.7% | -2,361.6% | -1,203% | -4,266.7% |
| EPS Diluted | -1.59 | -1.5 | -1.3 | -1.91 |
| % Growth | -6% | -15.4% | 31.9% | – |
| Operating Cash Flow | -€66,618 | -€70,339 | -€85,175 | -€69,531 |
| Capital Expenditures | -€63 | -€404 | -€236 | -€117 |
| Free Cash Flow | -€66,681 | -€70,743 | -€85,411 | -€69,648 |